Birchview Capital, LP Gilead Sciences, Inc. Transaction History

Birchview Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $621,000 - $780,800	-10,000 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $723,400 - $840,000	-10,000 Reduced 50.0%	10,000 $769,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $1.25 Million - $1.6 Million	20,000 New	20,000 $1.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.